Sangamo BioSciences | SGMO - رأس المال والاحتياطيات





رأس المال والاحتياطيات تغيير تاريخ
Alaunos Therapeutics USD 2.8M 858K 2025-09
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Alterity Therapeutics Limited AUD 22.81M 5.29M 2023-06
Amgen USD 8.66B 961M 2025-12
Bayer EUR 25.95B 3.75B 2025-12
BioCryst Pharmaceuticals USD -119.15M 268.74M 2025-12
Biogen USD 18.21B 573.5M 2025-09
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Cipla INR 329.19B 16.3B 2025-09
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 102.73M 58.9M 2025-12
CSL USD 18.66B 2.75B 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Grifols EUR 6.21B 133.12M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
J&J USD 78.47B 0 2025-09
Karyopharm Therapeutics USD -269.26M 30.33M 2025-09
Merck USD 51.85B 2.79B 2025-09
Novartis USD 46.13B 1.38B 2025-12
Omeros USD -228.68M 15.13M 2025-06
Pfizer USD 92.8B 4.11B 2025-09
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sanofi EUR 71.71B 1.55B 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Tectonic Therapeutic USD 251.33M 16.2M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12